Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of lyophilized recombinant human brain natriuretic peptide in acute heart failure
CTR20251088Phase 3Active
- Sponsor
- Shijiazhuang Wotai Biotechnology
- Start
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of nesiritide in Acute Heart Failure (AHF), sponsored by Shijiazhuang Wotai Biotechnology. Started Jun 2025; status: active.
02
Drugs
nesiritide
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on CTR20251088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251088.